Consolidated Statement of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flow from operating activities
Net loss	$ (1,288,558)	$ (4,723,720)
Adjustment for non-cash charges and other items:
Depreciation	5,831	3,349
Amortization of deferred debt issuance costs	3,480	0
Stock compensation expense	195,266	3,139,920
Change in fair value of derivative instrument	0	213,053
Gain on debt extinguishment	0	(96,145)
Gain on settlement of accounts payable	0	(156,616)
Amortization of debt discount	3,629	0
Total adjustments	(1,080,352)	(1,620,159)
Changes in working capital
Decrease / (increase) in accounts receivable	(9,206)	12,936
Decrease / (increase) in inventory	(57,106)	0
Decrease / (increase) in prepaid inventory	62,040	0
Decrease / (increase) in prepaid expenses	(3,900)	9,402
(Decrease) / increase in trade and other payables	(12,079)	(61,688)
(Decrease) / increase in accrued expenses	29,883	73,424
(Decrease) / increase in accrued expenses - related party	26,814	(207,444)
(Decrease) / increase in deferred revenue	(11,874)	(13,283)
Total changes in working capital	24,572	(186,653)
Cash flow used in operating activities	(1,055,780)	(1,806,812)
Cash flow from investing activities
Purchase of property and equipment	(9,442)	(50,000)
Cash flow used in financing activities	(9,442)	(50,000)
Cash flow from financing activities
Proceeds from note payable	0	25,000
Proceeds received from related parties	155,800	0
Proceeds from issuance of convertible notes	240,000	0
Proceeds from issuance of stock for cash	659,500	3,300,000
Repayments of note payable	(15,109)	(685,510)
Payments to related parties	0	(30,155)
Cash flow provided by financing activities	1,040,191	2,609,335
(Decrease) Increase in cash and cash equivalents	(25,031)	752,523
Cash and cash equivalents at the beginning of the period	70,505	847,430
Cash and cash equivalents at end of the period	45,474	1,599,953
Interest	0	0
Taxes	$ 0	$ 0